HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

hibarimicinone

a v-Src kinase inhibitor; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycosides: 2119
  - hibarimicinone: 1
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        hibarimicinone: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - hibarimicinone: 1

Experts

1.	Cho, Sung Ig: 1 article (03/2002)
2.	Fukazawa, Hidesuke: 1 article (03/2002)
3.	Furumai, Tamotsu: 1 article (03/2002)
4.	Honma, Yoshio: 1 article (03/2002)
5.	Hori, Hiroshi: 1 article (03/2002)
6.	Igarashi, Yasuhiro: 1 article (03/2002)
7.	Kajiura, Takayuki: 1 article (03/2002)
8.	Oki, Toshikazu: 1 article (03/2002)
9.	Uehara, Yoshimasa: 1 article (03/2002)

Related Diseases

1.	Myeloid Leukemia (Leukemia, Myelocytic) 03/01/2002 - "hibaria [glycosides (hibarimicins A, B, C, D, E, G, H and I) and aglycon (hibarimicinone)] or compounds produced by its mutants [glycosides (HMP-P4 and -Y6), aglycons (HMP-P1 and -Y1) and shunt products (HMP-M1, M2, M3 and -M4)] on v-Src tyrosine kinase and growth and differentiation of human myeloid leukemia HL-60 cells. "

Related Drugs and Biologics

1.	src-Family Kinases
2.	Glycosides